Activation of G protein-coupled receptor 30 by thiodiphenol promotes proliferation of estrogen receptor α-positive breast cancer cells
- 1 February 2017
- journal article
- Published by Elsevier in Chemosphere
- Vol. 169, 204-211
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (21507078, 41430644, 41373098)
- State Key Laboratory of Organic Geochemistry (OGL-201410)
- Program for Changjiang Scholars and Innovative Research Team in University (IRT13078)
This publication has 43 references indexed in Scilit:
- Involvement of activating ERK1/2 through G protein coupled receptor 30 and estrogen receptor α/β in low doses of bisphenol A promoting growth of Sertoli TM4 cellsToxicology Letters, 2014
- GPCR-mediated rapid, non-genomic actions of steroids: Comparisons between DmDopEcR and GPER1 (GPR30)General and Comparative Endocrinology, 2014
- Opposite effects of tamoxifen on metabolic syndrome‐induced bladder and prostate alterations: A role for GPR30/GPER?The Prostate, 2013
- The toxic effects of Aroclor 1254 exposure on the osteoblastic cell line MC3T3-E1 and its molecular mechanismToxicology, 2012
- The G protein-coupled receptor GPR30 mediates the proliferative and invasive effects induced by hydroxytamoxifen in endometrial cancer cellsBiochemical and Biophysical Research Communications, 2012
- Hexachlorobenzene induces cell proliferation and IGF-I signaling pathway in an estrogen receptor α-dependent manner in MCF-7 breast cancer cell lineToxicology Letters, 2010
- The G Protein–Coupled Receptor GPR30 Inhibits Proliferation of Estrogen Receptor–Positive Breast Cancer CellsCancer Research, 2010
- Low Doses of Bisphenol A Promote Human Seminoma Cell Proliferation by Activating PKA and PKG via a Membrane G-Protein–Coupled Estrogen ReceptorEnvironmental Health Perspectives, 2009
- Retracted: G-Protein–Coupled Receptor 30 and Estrogen Receptor-α Are Involved in the Proliferative Effects Induced by Atrazine in Ovarian Cancer CellsEnvironmental Health Perspectives, 2008
- PI3K/Akt signalling pathway and cancerCancer Treatment Reviews, 2004